肝细胞癌的肝脏导向治疗:技术、结局与治疗后影像表现概述
Liver-Directed Therapy for Hepatocellular Carcinoma: An Overview of Techniques, Outcomes, and Posttreatment Imaging Findings.
PubMed 文献 · AJR Am J Roentgenol · 2017-03-28
本文阐述肝细胞癌动脉导向治疗与消融的适应证、技术及结果,并综述影像学疗效评估与并发症。大多数肝细胞癌患者不适合手术且全身治疗欠佳,因此局部区域治疗在该病中发挥重要作用,包括动脉导向治疗、消融和放射治疗。
要点
- 大多数肝细胞癌患者不适合手术,全身治疗欠佳,局部区域治疗作用重要。
- 局部区域治疗包括动脉导向治疗、消融和放射治疗。
- 治疗后需影像学评估疗效与并发症。
核心结论
- 大多数肝细胞癌患者不适合手术且全身治疗欠佳,局部区域治疗在该病中发挥重要作用。
研究设计与样本
- 本文为概述性文章,描述动脉导向治疗与消融的适应证、技术和结果,并综述影像学疗效与并发症评估。
临床应用与阅片要点
- 局部区域治疗包括动脉导向治疗、消融和放射治疗,治疗后需影像学评估疗效与并发症。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purposes of this article are to describe the indications, techniques, and results of arterially directed therapies and ablation and to review the imaging assessment of response and complications.
CONCLUSION: Most patients with hepatocellular carcinoma are not eligible for surgery, and systemic treatments are suboptimal. Therefore, locoregional therapy plays a large role in this disease. Locoregional therapies include arterially directed therapies, ablation, and radiation therapy.
来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。
引用
- Covey AM, Hussain SM. Liver-Directed Therapy for Hepatocellular Carcinoma: An Overview of Techniques, Outcomes, and Posttreatment Imaging Findings. AJR Am J Roentgenol. 2017. PMID: 28350491. doi:10.2214/AJR.17.17799
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。